MA09.01 LCMC3: Immune Cell Subtypes Predict Nodal Status and Pathologic Response After Neoadjuvant Atezolizumab in Resectable NSCLC F. Oezkan,Michał T. Seweryn,Maciej Pietrzak,W.Y. Byun,Dwight H. Owen,Katja Schulze,Alan Nicholas,S. Hilz, J. Grindheim,A. Johnson,David J. Kwiatkowski, I. I. Wistuba,Bruce E. Johnson,Mark G. Kris,V. Rusch,Jivianne T. Lee,Gerard Lozanski,David P. CarboneJournal of Thoracic Oncology（2021）引用 8|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
